Corvus Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$27,029,000 over the previous period. Total operating expenses were $23,407,000.
Profit Margin
| 2014 | 0 | -175.63K | |
|---|---|---|---|
| 2015 | 0 | -31.33M | |
| 2016 | 0 | -36.37M | |
| 2017 | 0 | -55.66M | |
| 2018 | 0 | -46.93M | |
| 2019 | 0 | -43.74M | |
| 2020 | 0 | -4.82M | |
| 2021 | 0 | -38.2M | |
| 2022 | 0 | -50.04M | |
| 2023 | 0 | -27.02M |
CRVS Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 151K | 367K | 460K | 632K | 743K | 0 | 842K | 0 | 148K | 0 |
Gross profit | -151K | -367K | -460K | -632K | -743K | 0 | -842K | 0 | -148K | 0 |
Operating exp. | ||||||||||
Research and development | 16.52M | 24.46M | 29.11M | 31.83M | 37.97M | 38.58M | 46.30M | 29.35M | 11.35M | 41.45K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 23.40M | 32.56M | 38.63M | 43.76M | 48.85M | 49.22M | 56.52M | 36.97M | 13.77M | 175.63K |
Operating income | -23.40M | -32.56M | -38.63M | -43.76M | -48.85M | -49.22M | -56.52M | -36.97M | -13.77M | -175.63K |
Other income (expenses), net | -3.62M | -8.74M | -4.61M | 37.76M | 2.18M | 2.28M | 861K | 601K | -17.56M | 0 |
Income before tax | -27.02M | -41.30M | -43.24M | -5.99M | -46.67M | -46.93M | -55.66M | -36.37M | -31.33M | -175.63K |
Income tax expense | 0 | 8.74M | -5.04M | -1.17M | -2.92M | 2.28M | -842K | -594K | -35K | 0 |
Net income | -27.02M | -50.04M | -38.2M | -4.82M | -43.74M | -46.93M | -55.66M | -36.37M | -31.33M | -175.63K |
Earnings per share | ||||||||||
Basic EPS | -0.56 | -1.08 | -0.91 | -0.16 | -1.49 | -1.71 | -2.72 | -2.36 | -1.54 | -1.03 |
Diluted EPS | -0.56 | -1.08 | -0.91 | -0.16 | -1.49 | -1.71 | -2.72 | -2.36 | -1.54 | -1.03 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |